Related Experiment Video
Updated: Oct 19, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Filamin C in cardiomyopathy: from physiological roles to DNA variants
Shen Song1, Anteng Shi1, Hong Lian1
1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.
Insights
Mutations in the Filamin C (FLNC) gene are linked to various cardiomyopathies. Understanding FLNC
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiomyopathy is a leading cause of death, with familial cases often linked to genetic mutations.
- Filamin C (FLNC) is crucial for sarcomere stability and its mutations are implicated in myofibrillar myopathy and cardiomyopathy.
- Recent findings highlight FLNC mutations as critical in cardiomyopathy pathogenesis.
Purpose of the Study:
- To review the physiological roles of Filamin C in cardiomyocytes.
- To summarize genetic evidence linking FLNC mutations to cardiomyopathies.
- To elucidate pathomechanisms in FLNC-related cardiomyopathy.
Main Methods:
- Literature review of studies on FLNC gene and cardiomyopathy.
- Analysis of FLNC protein variants (truncated vs. non-truncated) in different cardiomyopathy types.
- Summary of described pathomechanisms including protein aggregation and haploinsufficiency.
Main Results:
- Truncated FLNC is associated with dilated and arrhythmogenic right ventricular cardiomyopathy.
- Non-truncated FLNC is linked to hypertrophic and restrictive cardiomyopathy.
- Two key pathomechanisms identified: protein aggregation and haploinsufficiency.
Conclusions:
- FLNC mutations are a significant genetic cause of various cardiomyopathies.
- Different FLNC mutation types correlate with specific cardiomyopathy subtypes.
- Understanding FLNC biology is vital for developing targeted therapies for FLNC-related cardiomyopathies.
Abstract:
Cardiomyopathy affects approximately 1 in 500 adults and is the leading cause of death. Familial cases are common, and mutations in many genes are involved in cardiomyopathy, especially those in genes encoding cytoskeletal, sarcomere, and nuclear envelope proteins. Filamin C is an actin-binding protein encoded by filamin C (FLNC) gene and participates in sarcomere stability maintenance. FLNC was first demonstrated to be a causal gene of myofibrillar myopathy; recently, it has been found that FLNC mutation plays a critical role in the pathogenesis of cardiomyopathy. In this review, we summarized the physiological roles of filamin C in cardiomyocytes and the genetic evidence for links between FLNC mutations and cardiomyopathies. Truncated FLNC is enriched in dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy. Non-truncated FLNC is enriched in hypertrophic cardiomyopathy and restrictive cardiomyopathy. Two major pathomechanisms in FLNC-related cardiomyopathy have been described: protein aggregation resulting from non-truncating mutations and haploinsufficiency triggered by filamin C truncation. Therefore, it is important to understand the cellular biology and molecular regulation of FLNC to design new therapies to treat patients with FLNC-related cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cytoskeletal Linker Proteins - Plakins
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy

